Oncogene Alterations in Metastatic Gastric Carcinomas
Author Information
Author(s): T. Tsujino, K. Yoshida, H. Nakayama, H. Ito, T. Shimosato, E. Tahara
Primary Institution: Hiroshima University
Hypothesis
Are alterations in oncogenes associated with tumor progression and metastasis in gastric carcinomas?
Conclusion
The study found that oncogene alterations, particularly amplifications of ERBB and ERBB2, are significantly higher in metastatic gastric carcinomas compared to primary tumors.
Supporting Evidence
- Amplification of ERBB2 was found in 25% of metastatic tumors.
- ERBB and ERBB2 amplifications were significantly higher in metastatic tumors compared to primary tumors.
- Allelic deletion of the LMYC gene was observed in metastatic tumors with ERBB amplification.
Takeaway
This study looked at cancer samples to see if certain genes change when stomach cancer spreads, and they found that some genes were more likely to change in the spread of the disease.
Methodology
DNA from 121 gastric carcinoma samples was analyzed for oncogene alterations using Southern blot hybridization.
Limitations
The study primarily focused on specific oncogenes and may not account for other genetic factors involved in gastric carcinoma.
Participant Demographics
The study included 12 autopsy cases of gastric carcinomas with varying histological types.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website